Global Epigenetics Market Overview:
Epigenetics is the emerging field of science that studies heritable changes caused by the activation and deactivation (turn on or off) of genes without any change in the underlying DNA sequence of the organism. It was used to study the molecular processes that influence the flow of information between a constant DNA sequence and variable gene expression patterns. Epigenetic change is a regular & natural occurrence but can also be affected by several factors, including age, environment, lifestyle, and diseases. In epidemic research, a wide range of molecular biological techniques is used to understand better epigenetic phenomena, including methylation-sensitive restriction enzymes, fluorescent in situ hybridization, chromatin immunoprecipitation, DNA adenine methyltransferase identification, and bisulfite sequencing.
Global Epigenetics Market Insights:
The global Epigenetics market is likely to grow at a significant CAGR over the forecast period 2020-2027. The essential factors are the growing demand for epigenetics due to decreasing sequencing costs and increasing R&D investments. Additionally, the increasing utilization prevalence of cancers, degenerative disorders, and metabolic disorders and growing applications of epigenetics in non-oncology diseases will spur the global epigenetics industry in the future periods. Furthermore, the growing public-private funding for epigenetic research activities and growing applications of epigenetic in epidemiology and genomics research expected to witness remarkable growth of epigenetics. The emerging focus on epigenetic therapy and the increasing discovery of epigenetic drugs for cancer treatment is expected to propel the demand for epigenetics in the upcoming years. However, the upsurge in demand for personalized medicine and the rising emergence of novel drugs positively impact the market for epigenetics in the healthcare industry.
Furthermore, the rapidly expanding customer base, increment in the extensive R&D activities at the educational and industrial level, and increasing range of biomedical applications are fueling the demand for the epigenetics market. The increasing demand for early diagnosis and easy development of next-generation diagnostic technologies will bolster the growth of global Epigenetics market sales. Additionally, the growing geriatric population and growing healthcare graph in the developing world propelling the growth of the epigenetics market across the globe.
Growth Driver
Cancer is the main reason for death globally, and there has been a significant increase in the number of new cases. Epigenetics is clinically used in biomarkers and therapeutics. Epidemics changes such as dysregulation of DNA methylation are associated with cancer development. It provides new therapeutic strategies and drugs to reverse the dysregulation of cancers. Cancer research studies that utilize epigenetic techniques are in process and drives the market. In addition, the equipment to diagnose alterations in genetics, as well as epigenetic drugs to treat diseases, have attracted various pharmaceutical and biotechnology industries to the layout. However, the high cost of procedures and instruments can be a restraint to the growth of the epigenetics market.
Product Segmental Analysis
The global epigenetics market is segregated into enzymes, instruments & consumables, kits, reagents, and bioinformatics tools based on the product. The kits segment is estimated to witness the highest growth over the analysis timeframe due to the rise in adoption of kits in various epigenetics techniques, rising prevalence of genetic diseases, and increasing public funding for life science research.
The instruments & consumables will grow significantly due to the rising epigenetics system adoption, growing awareness over the availability of different techniques, and technological advancements related to epigenetics systems.
Technology Segmental Analysis
The global epigenetics market is categorized into DNA methylation, histone modifications, and others.
The DNA methylation segment held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to its ability to control gene expression and plays an essential role in cellular physiology. In addition, It is the most commonly used epigenetic signaling tool that can fix genes in the “off” position.
The histone modifications segment is poised to witness significant growth over the forecast period. It provides relevant information to better understand epigenetic regulation of cellular processes and the rising development of histone-modifying enzyme-targeted drugs.
Application Segmental Analysis
Based on the application, the global epigenetics market is classified into oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and others.
The oncology is expected to be the highest revenue share for epigenetics at the forecasting period. The segment’s growth is primarily centered on the increasing prevalence of cancer, rising demand for epigenetics therapies to treat cancer, and advancements in cancer disease detecting devices. In addition, epigenetics technology is used for deriving therapeutic strategies designed to reverse transcriptional abnormalities inherent to the cancer epigenome.
The non-oncology will witness a lucrative growth rate in the estimated period due to rising demand for biomarker detection for drug development, increasing R&D initiatives by the private institutions and biopharmaceutical companies to identify epigenetic markers and rising prevalence of cardiovascular and metabolic diseases.
End-User Segmental Analysis
Based on the end-user, the global epigenetics market is segmented into pharmaceuticals & biotechnology companies, academic & research institutes, and contract research organizations. The pharmaceutical and biomedical companies segment will dominate the global epigenetics market by 2027 due to the high rise in the number of pharmaceutical companies using epigenetics technology, increasing use of epigenetic instruments in the clinical trial setting, and rising demand for personalized medicine.
The academic and research institutes accounted for the largest share of the epigenetics market in 2019 due to increasing research in genomics, economic expansion, and government focus on broader healthcare policies.
Region Segmental Analysis
By geography, the global epigenetics market is segmented into North America, Europe, Asia Pacific, South America, and The Middle East & Africa. North America is to project considerable growth over 2020-2027. It is due to advents in technology, leading industry players offering innovative products, and increasing healthcare expenditure.
The Asia Pacific will get a prominent share of the Epigenetics market by 2027. Due to the increasing prevention of cancer, we are continually improving healthcare infrastructure in the region and mounting healthcare expenditures in developing countries such as India and China.
Competitor Analysis
Companies such as Thermo fisher scientific, Illumina, PerkinElmer, Bio-Rad, Qiagen, Agilent, Merck Millipore, Abcam, Diagnose, New England Biolab, Active Motif, and Zymo Research are the key players in the global epigenetics market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global epigenetics manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to epigenetics
- Regulatory bodies
- Suppliers
- Retailers
The objective of the research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can specifically be targeted.
Market Modelling
By Product
- Enzymes
- Instruments & Consumables
- Kits
- Reagents
- Bioinformatics tools
By Technology
- DNA Methylation
- Histone Modifications
- Others
By Application
- Oncology
- Metabolic Diseases
- Developmental Biology
- Immunology
- Cardiovascular Diseases
- Others
By End-User
- Pharmaceuticals and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Global Stem Cell Banking Market
Global Synthetic Stem Cells Market
Global Genetic Toxicology Testing Market
Global High-Content Screening Market
Global Flow Cytometry Market
Global Aseptic Sampling Market
Global Cell Culture Market
Global High Resolution Melting Analysis Market
Global Stem Cell Assays Market
Global Human Organoid Market